Response to 'Eruptive keratoacanthomas associated with dupilumab therapy'.

Skin Health Dis

Service de pharmacovigilance CHRU de Nancy Nancy France.

Published: June 2023

Case of a patient developing multiple rashes of squamous cell carcinoma 6 weeks after the introduction of dupilumab due to atopic eczema.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233080PMC
http://dx.doi.org/10.1002/ski2.197DOI Listing

Publication Analysis

Top Keywords

response 'eruptive
4
'eruptive keratoacanthomas
4
keratoacanthomas associated
4
associated dupilumab
4
dupilumab therapy'
4
therapy' case
4
case patient
4
patient developing
4
developing multiple
4
multiple rashes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!